Literature DB >> 19536851

Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease.

Nilesh R Ghugre1, Ignacio Gonzalez-Gomez, Ellen Butensky, Leila Noetzli, Roland Fischer, Roger Williams, Paul Harmatz, Thomas D Coates, John C Wood.   

Abstract

Patients with sickle cell disease (SCD) appear to be at lower risk of endocrinopathies and cardiac dysfunction than those with thalassemia major (TM). Circulating redox active iron is lower in these patients, possibly due to increased systemic inflammation and circulating cytokines. Hepcidin synthesis is upregulated during chronic inflammation, reducing intestinal iron absorption and promoting retention of iron in the reticuloendothelial cells. Hence, we hypothesized that livers of patients with SCD would exhibit greater iron deposition in sinusoidal spaces relative to hepatocytes and less in portal tracts when compared to patients with TM. To test this hypothesis, iron scoring analysis was performed on 70 clinically indicated liver biopsy specimens from children and young adults with the two syndromes. Sinusoidal scores were lower in around 1 of 4 patients with TM but the relative iron loading in hepatocytes, and portal tracts was identical in both diseases. Sinusoidal iron burdens saturated at low hepatic iron concentration (HIC) while hepatocyte and portal iron depots increased proportionally to HIC. Liver fibrosis was increased in patients with TM regardless of their chronic hepatitis status. Overall, liver iron distribution was relatively insensitive to differences in disease type and to the presence or absence of hepatitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19536851      PMCID: PMC2884400          DOI: 10.1002/ajh.21456

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  26 in total

1.  Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.

Authors:  Patrick B Walter; Ellen B Fung; David W Killilea; Qing Jiang; Mark Hudes; Jacqueline Madden; John Porter; Patricia Evans; Elliott Vichinsky; Paul Harmatz
Journal:  Br J Haematol       Date:  2006-10       Impact factor: 6.998

2.  Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.

Authors:  Ellen B Fung; Paul Harmatz; Meredith Milet; Samir K Ballas; Laura De Castro; Ward Hagar; William Owen; Nancy Olivieri; Kim Smith-Whitley; Deepika Darbari; Winfred Wang; Elliott Vichinsky
Journal:  Am J Hematol       Date:  2007-04       Impact factor: 10.047

3.  Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil.

Authors:  John C Wood; Maya Otto-Duessel; Ignacio Gonzalez; Michelle I Aguilar; Hiro Shimada; Hanspeter Nick; Marvin Nelson; Rex Moats
Journal:  Transl Res       Date:  2006-11       Impact factor: 7.012

4.  Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease.

Authors:  Ellen B Fung; Paul R Harmatz; Phillip D K Lee; Meredith Milet; Rita Bellevue; Michael R Jeng; Karen A Kalinyak; Mark Hudes; Suruchi Bhatia; Elliott P Vichinsky
Journal:  Br J Haematol       Date:  2006-10-10       Impact factor: 6.998

5.  The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major.

Authors:  Antonis Kattamis; Ioannis Papassotiriou; Danai Palaiologou; Filia Apostolakou; Angeliki Galani; Vassilis Ladis; Nikos Sakellaropoulos; George Papanikolaou
Journal:  Haematologica       Date:  2006-06       Impact factor: 9.941

6.  Circumstances of death in adult sickle cell disease patients.

Authors:  Deepika S Darbari; Paul Kple-Faget; John Kwagyan; Sohail Rana; Victor R Gordeuk; Oswaldo Castro
Journal:  Am J Hematol       Date:  2006-11       Impact factor: 10.047

Review 7.  Molecular pathogenesis of anemia of chronic disease.

Authors:  Tomas Ganz
Journal:  Pediatr Blood Cancer       Date:  2006-05-01       Impact factor: 3.167

8.  Urinary hepcidin in congenital chronic anemias.

Authors:  Susan L Kearney; Elizabeta Nemeth; Ellis J Neufeld; Dharma Thapa; Tomas Ganz; David A Weinstein; Melody J Cunningham
Journal:  Pediatr Blood Cancer       Date:  2007-01       Impact factor: 3.167

9.  Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.

Authors:  Ellen B Fung; Paul R Harmatz; Meredith Milet; Vinod Balasa; Samir K Ballas; James F Casella; Lee Hilliard; Abdullah Kutlar; Kenneth L McClain; Nancy F Olivieri; John B Porter; Elliott P Vichinsky
Journal:  Transfusion       Date:  2008-05-29       Impact factor: 3.157

10.  Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.

Authors:  Naoki Fujita; Ryosuke Sugimoto; Masaki Takeo; Naohito Urawa; Rumi Mifuji; Hideaki Tanaka; Yoshinao Kobayashi; Motoh Iwasa; Shozo Watanabe; Yukihiko Adachi; Masahiko Kaito
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

View more
  9 in total

1.  Imaging and quantification of iron-oxide nanoparticles (IONP) using MP-RAGE and UTE based sequences.

Authors:  Wen Hong; Qun He; Shujuan Fan; Michael Carl; Hongda Shao; Jun Chen; Eric Y Chang; Jiang Du
Journal:  Magn Reson Med       Date:  2016-08-06       Impact factor: 4.668

2.  Rosette Trajectories Enable Ungated, Motion-Robust, Simultaneous Cardiac and Liver T2 * Iron Assessment.

Authors:  Adam M Bush; Christopher M Sandino; Shreya Ramachandran; Frank Ong; Nicholas Dwork; Evan J Zucker; Ali B Syed; John M Pauly; Marcus T Alley; Shreyas S Vasanawala
Journal:  J Magn Reson Imaging       Date:  2020-05-26       Impact factor: 4.813

3.  Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload.

Authors:  Jane S Hankins; Matthew P Smeltzer; M Beth McCarville; Banu Aygun; Claudia M Hillenbrand; Russell E Ware; Mihaela Onciu
Journal:  Eur J Haematol       Date:  2010-03-31       Impact factor: 2.997

4.  Relaxivity-iron calibration in hepatic iron overload: probing underlying biophysical mechanisms using a Monte Carlo model.

Authors:  Nilesh R Ghugre; John C Wood
Journal:  Magn Reson Med       Date:  2010-11-16       Impact factor: 4.668

5.  ISMRM workshop on fat-water separation: insights, applications and progress in MRI.

Authors:  Houchun Harry Hu; Peter Börnert; Diego Hernando; Peter Kellman; Jingfei Ma; Scott Reeder; Claude Sirlin
Journal:  Magn Reson Med       Date:  2012-06-12       Impact factor: 4.668

6.  Relaxivity-iron calibration in hepatic iron overload: Reproducibility and extension of a Monte Carlo model.

Authors:  Changqing Wang; Scott B Reeder; Diego Hernando
Journal:  NMR Biomed       Date:  2021-08-30       Impact factor: 4.044

7.  Relaxivity-iron calibration in hepatic iron overload: Predictions of a Monte Carlo model.

Authors:  Nilesh R Ghugre; Eamon K Doyle; Pippa Storey; John C Wood
Journal:  Magn Reson Med       Date:  2014-09-19       Impact factor: 4.668

8.  Prolonged exposure to welding fumes as a novel cause of systemic iron overload.

Authors:  Raffaella Mariani; Sara Pelucchi; Valentina Paolini; Michael Belingheri; Filiberto di Gennaro; Paola Faverio; Michele Riva; Alberto Pesci; Alberto Piperno
Journal:  Liver Int       Date:  2021-03-22       Impact factor: 5.828

Review 9.  Myelodysplastic Syndromes and Iron Chelation Therapy.

Authors:  Emanuele Angelucci; Silvana Anna Maria Urru; Federica Pilo; Alberto Piperno
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-03-01       Impact factor: 2.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.